{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:01:10Z","timestamp":1792270870037,"version":"4.4.0"},"reference-count":47,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is characterized by immune cell dysfunction and poor prognosis. CD44, a cell surface glycoprotein with multiple splice variants, has been implicated in tumor progression, but its compartment-specific roles in PDAC remain unclear. CD44 standard and variant isoform expression was analyzed in patient-derived lymph nodes (LNs) by quantitative PCR. Immune cell-specific CD44 expression was assessed by flow cytometry in LNs and peripheral blood. Soluble and exosome-associated CD44 (exo-CD44) were measured in plasma. Clinical associations and survival analyses were performed. Transcriptomic, immune infiltration, immune checkpoint, and drug sensitivity analyses were conducted using TCGA-PAAD and pharmacogenomic datasets. CD44 standard isoform expression was unchanged in PDAC LNs, whereas multiple CD44 variant isoforms (v4\u2013v10) were significantly reduced and associated with metastatic disease and poor survival, particularly CD44v5, v6, v7, and v10. CD44 expression was enriched in CD45+ immune cells, with highest levels in CD4+ T cells in both LNs and blood. Soluble CD44 levels showed no clinical associations. In contrast, exo-CD44 levels were reduced overall in PDAC but increased in patients with distant metastasis, positive resection margins, systemic inflammation, and reduced survival. High CD44 expression was associated with advanced disease, immune cell infiltration, immune checkpoint gene expression, reduced sensitivity to gemcitabine, paclitaxel, rapamycin, and FMK, and distinct CTLA4\/PD-L1 checkpoint profiles. CD44 exhibits compartment-specific regulation in PDAC, linking immune remodeling, exosome signaling, and therapeutic resistance to adverse clinical outcome.<\/jats:p>","DOI":"10.3390\/cells15050411","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:31:19Z","timestamp":1772181079000},"page":"411","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.3390","volume":"15","author":[{"given":"Alara","family":"Karabiber","sequence":"first","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1716-3547","authenticated-orcid":false,"given":"Anke","family":"Mittelst\u00e4dt","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-1189","authenticated-orcid":false,"given":"Frederik Johannes","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Litau","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9672-0973","authenticated-orcid":false,"given":"Isabelle","family":"Kuchenreuther","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Mazurie","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn Niklas","family":"Clausen","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kl\u00f6ckner","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Czubayko","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Weisel","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Kl\u00f6sch","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talida","family":"Andert-Veres","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kr\u00f6ber","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-9486","authenticated-orcid":false,"given":"Susanne","family":"Merkel","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-5517","authenticated-orcid":false,"given":"Andreas R. R.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Brunner","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-5824","authenticated-orcid":false,"given":"Christian","family":"Krautz","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-4505","authenticated-orcid":false,"given":"Georg F.","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9643-3657","authenticated-orcid":false,"given":"Paul","family":"David","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer-clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-019-1345-6","article-title":"Pancreatic ductal adenocarcinoma: Biological hallmarks, current status, and future perspectives of combined modality treatment approaches","volume":"14","author":"Orth","year":"2019","journal-title":"Radiat. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Karamitopoulou, E. (2020). The Tumor Microenvironment of Pancreatic Cancer. Cancers, 12.","DOI":"10.3390\/cancers12103076"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10555-025-10297-9","article-title":"Lymphatic metastasis in pancreatic cancer: From bedside to bench and back","volume":"44","author":"Shi","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","article-title":"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: Therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hassn Mesrati, M., Syafruddin, S.E., Mohtar, M.A., and Syahir, A. (2021). CD44: A Multifunctional Mediator of Cancer Progression. Biomolecules, 11.","DOI":"10.3390\/biom11121850"},{"key":"ref_9","first-page":"6724","article-title":"Expression of CD44 in pancreatic cancer and its significance","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.cellsig.2014.07.011","article-title":"Regulation of alternative splicing of CD44 in cancer","volume":"26","author":"Prochazka","year":"2014","journal-title":"Cell Signal."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Maltseva, D., and Tonevitsky, A. (2023). RNA-binding proteins regulating the CD44 alternative splicing. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1326148"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yanova, M., Stepanova, E., Maltseva, D., and Tonevitsky, A. (2025). CD44 variant exons induce chemoresistance by modulating cell death pathways. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1508577"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Geloso, M.C., Ria, F., Corvino, V., and Di Sante, G. (2025). Expression of CD44 and Its Spliced Variants: Innate and Inducible Roles in Nervous Tissue Cells and Their Environment. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178223"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","article-title":"CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy","volume":"22","author":"Zhao","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Szatanek, R., and Baj-Krzyworzeka, M. (2021). CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031463"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","article-title":"Emerging role of exosomes in cancer progression and tumor microenvironment remodeling","volume":"15","author":"Paskeh","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.eng.2020.08.013","article-title":"Exosomal CD44 Cooperates with Integrin \u03b16\u03b24 to Support Organotropic Metastasis via Regulating Tumor Cell Motility and Target Host Cell Activation","volume":"7","author":"Mu","year":"2021","journal-title":"Engineering"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/s41467-025-63718-2","article-title":"Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: A phase I study with immunological correlates","volume":"16","author":"Kalluri","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"David, P., Kouhestani, D., Hansen, F.J., Paul, S., Czubayko, F., Karabiber, A., Weisel, N., Kl\u00f6sch, B., Merkel, S., and Ole-Baur, J. (2025). Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26041500"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mittelst\u00e4dt, A., Anthuber, A., David, P., Podolska, M., B\u00e9nard, A., Brunner, M., Krautz, C., Jacobsen, A., Denz, A., and Weber, K. (2024). Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1253072"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Lu, Y., Czubayko, F., Chen, J., Zheng, S., Mo, H., Liu, R., Weber, G.F., Gr\u00fctzmann, R., and Pilarsky, C. (2025). Identification of Cancer Associated Fibroblasts Related Genes Signature to Facilitate Improved Prediction of Prognosis and Responses to Therapy in Patients with Pancreatic Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104876"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40164-025-00672-1","article-title":"Multi-omics analyses of the heterogenous immune microenvironment in triple-negative breast cancer implicate UQCRFS1 potentiates tumor progression","volume":"14","author":"Tang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Xu, Q., Chen, S., Hu, Y., and Huang, W. (2021). Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.711433"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biochi.2025.10.015","article-title":"Isoform switching in the CD44\/ESRP1 axis as a driver of EMT and cancer stemness across tumor types","volume":"240","author":"Jankowska","year":"2026","journal-title":"Biochimie"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2195363","DOI":"10.1080\/15384047.2023.2195363","article-title":"The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development","volume":"24","author":"Boman","year":"2023","journal-title":"Cancer Biol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/pcmr.12307","article-title":"Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome","volume":"28","author":"Marzese","year":"2015","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"114095","DOI":"10.18632\/oncotarget.23125","article-title":"CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model","volume":"8","author":"Mayr","year":"2017","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"19634","DOI":"10.18632\/oncotarget.3839","article-title":"CD44 enhances tumor aggressiveness by promoting tumor cell plasticity","volume":"6","author":"Paulis","year":"2015","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3516973","DOI":"10.1155\/2019\/3516973","article-title":"The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery","volume":"2019","author":"Sun","year":"2019","journal-title":"J. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1724600817746951","article-title":"CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer","volume":"33","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12935-025-03748-4","article-title":"CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker","volume":"25","author":"Zhu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1002\/mco2.554","article-title":"CD44 and its implication in neoplastic diseases","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"217713","DOI":"10.1016\/j.canlet.2025.217713","article-title":"CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer","volume":"622","author":"Tang","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-021-04258-7","article-title":"Extracellular vesicles in pancreatic cancer progression and therapies","volume":"12","author":"Chang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gama, J.M., and Oliveira, R.C. (2025). CD44 and Its Role in Solid Cancers\u2014A Review: From Tumor Progression to Prognosis and Targeted Therapy. Front. Biosci., 30.","DOI":"10.31083\/FBL24821"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13111","DOI":"10.1111\/bpa.13111","article-title":"Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas","volume":"33","author":"Petterson","year":"2023","journal-title":"Brain Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.1038\/s41598-023-33915-4","article-title":"CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.immuni.2009.10.011","article-title":"CD44 Regulates Survival and Memory Development in Th1 Cells","volume":"32","author":"Baaten","year":"2010","journal-title":"Immunity"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.ajpath.2013.01.003","article-title":"CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis: A Role in Immune Cells and Vascular Cells of the Blood\u2013Brain Barrier","volume":"182","author":"Flynn","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/cib.3.6.13495","article-title":"Multifaceted regulation of T cells by CD44","volume":"3","author":"Baaten","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc\u2212 and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tips.2011.03.010","article-title":"Pharmacogenomics and cancer stem cells: A changing landscape?","volume":"32","author":"Crea","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Strecker, M., Zohar, K., B\u00f6ttcher, M., Wartmann, T., Freudenstein, H., Doelling, M., Andric, M., Shi, W., Kakhlon, O., and Hippe, K. (Mol. Oncol., 2025). Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity, Mol. Oncol., early view.","DOI":"10.1002\/1878-0261.70129"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"(2009). News & Views in \u2026 Pharmacogenomics. Pharmacogenomics, 10, 1035\u20131037.","DOI":"10.2217\/pgs.09.70"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1541-7786.MCR-09-0237","article-title":"Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature technology","volume":"9","author":"Cain","year":"2011","journal-title":"Mol. Cancer Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/5\/411\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:43:44Z","timestamp":1772181824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/5\/411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cells15050411"],"URL":"https:\/\/doi.org\/10.3390\/cells15050411","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}